Antisense Oligonucleotide Treatment of Inflammatory Bowel Diseases

Our expanding knowledge of inflammatory mediator pathways has created new options for the management of Crohn’s disease and ulcerative colitis (1 ). In the past decade, the differential immune activation of intestinal and peripheral immune systems has been identified, and these observations have rapidly moved basic science observations to the bedside, as biological therapies continue to increase.

内容来源:生物资料网,如果侵权麻烦联系网站工作人员删除!

艾美捷科技优势代理品牌

发表评论

:?: :razz: :sad: :evil: :!: :smile: :oops: :grin: :eek: :shock: :???: :cool: :lol: :mad: :twisted: :roll: :wink: :idea: :arrow: :neutral: :cry: :mrgreen: